SCHEMBL6766537

SCHEMBL6766537

CCCc1nn(-c2cccc(OC)c2)c2c1C(=O)CC(C)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
SLC5A1 P13866 2/20 0.39
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
RAB9A P51151 3/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
S1PR4 O95977 1/20 0.39
TP53 P04637 1/20 0.39
S1PR1 P21453 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GSK3B P49841 1/20 0.39
DCTPP1 Q9H773 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771042 0.87 ALDH1A1 (0.44) ALDH1A1LMNASLC5A1RAB9AHTT
SCHEMBL6766574 0.87 ALDH1A1 (0.39) ALDH1A1LMNASLC5A1USP2SMN1; SMN2
SCHEMBL6164477 0.85 ABCG2 (0.43) ALDH1A1LMNAHPGDHTTKMT2A
SCHEMBL6772063 0.84 OPRM1 (0.48) SMN1; SMN2RAB9AHTTKMT2ANPSR1
SCHEMBL6777584 0.83 ALDH1A1 (0.53) ALDH1A1LMNAUSP2SMN1; SMN2RAB9A
SCHEMBL6772144 0.81 RIPK2 (0.36) SLC5A1SMN1; SMN2RAB9AHPGDHTT
SCHEMBL6772323 0.81 GPBAR1 (0.41) ALDH1A1LMNASMN1; SMN2RAB9AHPGD
SCHEMBL6770581 0.81 ALDH1A1 (0.62) ALDH1A1LMNAKMT2ATP53NPSR1
SCHEMBL6775862 0.81 ABCG2 (0.39) ALDH1A1LMNASMN1; SMN2RAB9AHPGD
SCHEMBL6766708 0.81 RIPK2 (0.48) ALDH1A1LMNASMN1; SMN2RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed